Mechanism of osteogenic induction by FK506 via BMP/Smad pathways

This publication has 32 references indexed in Scilit:

• Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes
  Genes & Development, 2004
• Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506
  Bone, 2004
• Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats
  Gene Therapy, 2004
• Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans
  Spine, 2002
• Proteasomal Degradation of Smad1 Induced by Bone Morphogenetic Proteins
  Journal of Biological Chemistry, 2001
• Effects of Immunosuppressants on Receptor Activator of NF-κB Ligand and Osteoprotegerin Production by Human Osteoblastic and Coronary Artery Smooth Muscle Cells
  Biochemical and Biophysical Research Communications, 2001
• RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATION
  Transplantation, 1996
• THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVO
  Transplantation, 1994
• FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
  Nature, 1992
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
  Cell, 1991